[
  {
    "ts": "2025-06-26T08:08:08+00:00",
    "headline": "5 Revealing Analyst Questions From Hologic’s Q1 Earnings Call",
    "summary": "Hologic’s first quarter saw results broadly in line with Wall Street expectations, yet the company’s shares declined after the report as investors digested softer demand in select segments and international pressures. Management pointed to strong recurring revenue growth—especially in breast health services—as a stabilizing factor, while acknowledging that tariff costs and funding cuts in Africa weighed on diagnostic sales. CEO Steve MacMillan highlighted, “our Diagnostics business continued to",
    "url": "https://finance.yahoo.com/news/5-revealing-analyst-questions-hologic-080808835.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "f3b60912-869b-38b4-949d-27d6f7e03f87",
      "content": {
        "id": "f3b60912-869b-38b4-949d-27d6f7e03f87",
        "contentType": "STORY",
        "title": "5 Revealing Analyst Questions From Hologic’s Q1 Earnings Call",
        "description": "",
        "summary": "Hologic’s first quarter saw results broadly in line with Wall Street expectations, yet the company’s shares declined after the report as investors digested softer demand in select segments and international pressures. Management pointed to strong recurring revenue growth—especially in breast health services—as a stabilizing factor, while acknowledging that tariff costs and funding cuts in Africa weighed on diagnostic sales. CEO Steve MacMillan highlighted, “our Diagnostics business continued to",
        "pubDate": "2025-06-26T08:08:08Z",
        "displayTime": "2025-06-26T08:08:08Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/79dab4cf82f2f6c9517c9ca1f86b9ec6",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "HOLX Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IA27MUxQWSS5U_aghxi8Pw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/79dab4cf82f2f6c9517c9ca1f86b9ec6.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AP1CY6lUwaLn8kK9D5f25Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/79dab4cf82f2f6c9517c9ca1f86b9ec6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/5-revealing-analyst-questions-hologic-080808835.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/5-revealing-analyst-questions-hologic-080808835.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HOLX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]